Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

4,6,8-trihydroxy-10-(3,7,11-trimethyldodeca-2,6,10-trienyl)-5,10-dihydrodibenzo[b,e][1,4]diazepin-11-one

EU orphan designation number: EU/3/09/639
Active ingredient: 4,6,8-trihydroxy-10-(3,7,11-trimethyldodeca-2,6,10-trienyl)-5,10-dihydrodibenzo[b,e][1,4]diazepin-11-one
Indication: Treatment of glioma
Sponsor: Albany Regulatory Consulting Limited
Sumpter House, 8 Station Road, Histon, Cambridge CB4 9LQ, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/05/2009 Centralised Orphan - Designation EMEA/OD/004/09 (2009)4059 of 15/05/2009
16/07/2012 Centralised Orphan - Removal of orphan designation from Community Register